Cargando…

The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin

Aim. The usefulness of photodynamic therapy (PDT) for treating sentinel lymph node (SLN) metastasis was evaluated. Materials and Methods. Verteporfin, a hydrophobic photosensitizer, forms a soluble aggregate with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) (PMB). The conce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimada, Kyosuke, Matsuda, Sachiko, Jinno, Hiromitsu, Kameyama, Noriaki, Konno, Tomohiro, Arai, Tsunenori, Ishihara, Kazuhiko, Kitagawa, Yuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394349/ https://www.ncbi.nlm.nih.gov/pubmed/28473989 http://dx.doi.org/10.1155/2017/7412865

Ejemplares similares

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

Non-orthogonality and electron correlations in nanotransport
por: Fransson, J
Publicado: (2004)

Establishment of a model of sentinel lymph node metastasis using immunodeficient swine
por: Kurihara, Toshiaki, et al.
Publicado: (2019)

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)

Red Upconverter Nanocrystals Functionalized with Verteporfin for Photodynamic Therapy Triggered by Upconversion
por: Miletto, Ivana, et al.
Publicado: (2022)

Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates
por: Quadir, Mohiuddin, et al.
Publicado: (2018)

Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease
por: Bhattacharjee, Harsha, et al.
Publicado: (2010)

Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
por: Suh, Shin Cho, et al.
Publicado: (2007)

Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Noh, Sung Rae, et al.
Publicado: (2019)

Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery
por: Skalickova, Sylvie, et al.
Publicado: (2017)

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
por: Sobolev, Alexander S.
Publicado: (2018)

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne(®)), in the CAM model
por: Debefve, E., et al.
Publicado: (2008)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
por: Pece, Alfredo, et al.
Publicado: (2010)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
por: Huggett, M T, et al.
Publicado: (2014)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
por: Iacono, Pierluigi, et al.
Publicado: (2020)

Photoproducts of the Photodynamic Therapy Agent Verteporfin Identified via Laser Interfaced Mass Spectrometry
por: Furlan, Chris, et al.
Publicado: (2020)

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
por: Michy, Thierry, et al.
Publicado: (2019)

Preparation, cytotoxicity, and in vivo antitumor efficacy of (111)In-labeled modular nanotransporters
por: Slastnikova, Tatiana A, et al.
Publicado: (2017)

Layered Double Hydroxide Nanotransporter for Molecule Delivery to Intact Plant Cells
por: Bao, Wenlong, et al.
Publicado: (2016)

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin
por: Kawakami, Setsuko, et al.
Publicado: (2013)

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK
por: Claxton, Lindsay, et al.
Publicado: (2014)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani, Nadeem Ali, et al.
Publicado: (2017)

Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

β-Lactoglobulin as a Nanotransporter for Glabridin: Exploring the Binding Properties and Bioactivity Influences
por: Wei, Yongqin, et al.
Publicado: (2018)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
por: Tsuchihashi, Takashi, et al.
Publicado: (2013)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2014)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
por: Fernández, Maribel, et al.
Publicado: (2012)

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)

Thermo-responsive triple-function nanotransporter for efficient chemo-photothermal therapy of multidrug-resistant bacterial infection
por: Qing, Guangchao, et al.
Publicado: (2019)

Targeted Delivery of (111)In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
por: Karyagina, Tatiana S., et al.
Publicado: (2020)

Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
por: Jain, Prashant, et al.
Publicado: (2018)

Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
por: Lu, Jingjing, et al.
Publicado: (2019)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
por: Fujita, Kyoko, et al.
Publicado: (2020)

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas
por: Rytlewski, Jeffrey D., et al.
Publicado: (2021)

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Kumashiro, Shun, et al.
Publicado: (2021)

Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting (125)I
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_73jn9s6u2ftjqsblmekuticu6c